YTHDF1 and neoplasm: Another research found that anti-tumour immunity in dendritic cells (DCs) was regulated by the m6A-binding protein YTHDF1, and the deficiency of YTHDF1 enhanced the cross-presentation of tumour antigens on DCs by decreasing the translation of lysosomal proteases in DCs36.